特应性皮炎患者抗金黄色葡萄球菌抗原抗体反应患病率:系统综述与荟萃分析
结果显示AD患者抗葡萄球菌肠毒素A和B的IgE患病率显著高于对照,支持金黄色葡萄球菌在AD发病中的作用,但研究异质性和不精确性需考虑。
要点
- AD患者抗葡萄球菌IgE患病率:SEA为33%,SEB为35%,TSST-1为16%。
- IgG、IgM、IgA及其他抗原的数据有限,研究质量中等至差。
核心结论
- AD患者较健康对照更常出现针对金黄色葡萄球菌超抗原的IgE抗体反应,支持金黄色葡萄球菌在AD发病中的作用。
研究设计与样本
- 系统检索Embase、MEDLINE、Web of Science、Scopus、Cochrane、PubMed和Google Scholar至2016年2月12日,纳入评估AD患者血清抗葡萄球菌抗体的原始观察性和实验性研究。
- 使用随机效应模型合并IgE、IgG、IgM和IgA的患病率及比值比,计算I2统计量评估异质性,采用Newcastle-Ottawa量表评价研究质量。
主要发现
- AD患者抗葡萄球菌IgE患病率分别为SEA 33%、SEB 35%、TSST-1 16%。
- 关于IgG、IgM、IgA及其他抗原的数据有限。
关键数值与推荐
- 抗葡萄球菌IgE患病率:SEA 33%,SEB 35%,TSST-1 16%。
临床怎么用
- 临床可关注AD患者针对金黄色葡萄球菌超抗原的IgE致敏状态,但其检测的常规应用价值需进一步研究。
- 解释抗体结果时应考虑研究间异质性和不精确性。
局限性
- 研究异质性和不精确性需在解释结果时考虑。
- 研究质量中等至差(fair to poor)。
- IgG、IgM、IgA及其他抗原的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Staphylococcus aureus plays a role in the pathogenesis of atopic dermatitis (AD), possibly via the expression of various virulence antigens. An altered antibody response towards these antigens might contribute to inflammation. OBJECTIVES: To provide an overview of the varying prevalences and odds of antibody responses against S. aureus antigens in patients with AD. METHODS: Data were systematically obtained from Embase, MEDLINE, Web of Science, Scopus, Cochrane, PubMed and Google Scholar up to 12 February 2016. We selected all original observational and experimental studies assessing antistaphylococcal antibodies in serum of patients with AD. Prevalences and odds ratios (ORs) of IgE, IgG, IgM and IgA against S. aureus in patients with AD vs. healthy controls were pooled using the random-effects model. We calculated I2 statistics to assess heterogeneity and rated study quality using the Newcastle-Ottawa Scale. RESULTS: Twenty-six articles (2369 patients) were included, of which 10 were controlled studies. Study quality was fair to poor. Patients with AD had higher prevalences of IgE against staphylococcal enterotoxin (SE)A (OR 8·37, 95% confidence interval 2·93-23·92) and SEB (OR 9·34, 95% confidence interval 3·54-24·93) compared with controls. Prevalences of antistaphylococcal IgE were 33% for SEA, 35% for SEB and 16% for toxic shock syndrome toxin-1. However, study heterogeneity and imprecision should be taken into consideration when interpreting the results. Data on IgG, IgM and IgA, as well as other antigens, are limited. CONCLUSIONS: Patients with AD more often show an IgE antibody response directed against S. aureus superantigens than healthy controls, supporting a role for S. aureus in AD pathogenesis.
引用
- de Wit J, Totté JEE, van Buchem FJM, et al. The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2018. PMID: 29247497. doi:10.1111/bjd.16251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。